Predictive biomarkers in nonsmall cell carcinoma and their clinico-pathological association

BACKGROUND: Lung cancer is the leading cause of cancer-related mortality worldwide. Genome-directed therapy is less toxic, prolongs survival and provides a better quality of life. Predictive biomarker testing, therefore, has become a standard of care in advanced lung cancers. The objective of this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Anurag, Sriramanakoppa, Nayana N., Agarwal, Poojan, Viswakarma, Gayatri, Vasudevan, Smreti, Panigrahi, Manoj, Kumar, Dushyant, Saifi, Mumtaz, Chowdhary, Irfan, Doval, D. C., Suryavanshi, Moushumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
ORIGINAL ARTICLE: Lung Cancers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852638/
https://www.ncbi.nlm.nih.gov/pubmed/31807491
http://dx.doi.org/10.4103/sajc.sajc_373_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852638/
https://www.ncbi.nlm.nih.gov/pubmed/31807491
http://dx.doi.org/10.4103/sajc.sajc_373_18

Ejemplares similares